Main Content

Discovering Drug Therapies

Biochemist Judith Kelleher-Andersson, Ph.D., a member of the class of 1981, arrived at Saint Anselm College with an interest in forensics. It was not until she was hired as a lab assistant her junior year by biochemistry professor, Dr. Daniel Lavoie, that she began to realize her future might have something else in store for her.

Today, Kelleher-Andersson is the founder, president, and chief scientific officer of Neuronascent, Inc., a biotechnology startup in Clarksville, Maryland. She founded Neuronascent in 2004, and she has more than 70 U.S., European, and world patents. She works to discover drug therapies for neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, and depression.

In the summer of 1980 Kelleher-Andersson got her first taste of professional research, in a National Science Foundation (NSF) funded project looking at protein involved in infection. "It was important for my career. I didn't realize I enjoyed research so much."

Kelleher-Andersson went on to earn her Ph.D. in biochemistry at the University of Missouri and completed two post-doctoral studies in neurobiochemistry and neurology at the University of California.